Enhance your practice with CME and tools that focus on diseases and conditions impacting the female patient.
Escalate With Intention: Stepwise, Target-Anchored Moves
Christyn Edmundson, MD
Gil I. Wolfe MD, FAAN
The 2-Point Signal: Apply ≥2-Point Rule
Minimal By Design: Define MSE Endpoints
FcRn: Same Class, Different Paths—Spot Agent Differentiators
Target Locked in gMG: Why T2T Matters
Precision Starts Before Birth: Reimagining Fetal Care Through FcRn Immune Modulation
Kenneth J. Moise Jr., MD
Kara B. Markham, MD
Not Just a Headache: Migraine Across Women’s Lifespan
Jelena Pavlović, MD, PhD
Amaal J. Starling, MD, FAHS, FAAN
Primary Biliary Cholangitis: Shining Light on an "Invisible" Female Health Burden
Gideon Hirschfield, MB, BChir, PhD
Marlyn Mayo, MD
The IgG Clock: Redose Using IgG Kinetics
Scorecards That Matter: Use MG-ADL, MG-MMT, QMG, QoL
Turning Flares Into Function: Flag Uncontrolled Disease
Treat. Target. Transform: Applying Treat-to-Target Principles in the Management of Generalized Myasthenia Gravis (gMG)
ENDOVOICE Live: Endometriosis—A Chronic Burden of Reproductive Years
Linda Bradley, MD
Obianuju Sandra Madueke-Laveaux, MD, MPH
Lauren R. Kornegay
Diagnosing and Treating IBS: It Begins With One Simple Question
Brooks D. Cash, MD, AGAF, FACG, FACP, FASGE
Kimberly D. Orleck, PA-C
Women’s Sleep Health – Addressing Gaps in OSA Diagnosis and Treatment Across Life Stages
Alison Kole, MD, MPH, FACCP
Ghada Bourjeily, MD, FCCP
Rashmi Nisha Aurora, MD
Audrey Wells, MD
It’s Not Just Black and White: Seeing the Full Spectrum of Endometriosis Cases
Melissa Simon, MD
Casey Joe Hinds
Shared Goals, Shared Gains: Align With Patient Preferences
The Alloimmune Disorders of Pregnancy
Karin J. Blakemore, MD
Emilie L. Vander Haar
Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT): Overcoming Diagnostic and Therapeutic Challenges
Clinical Considerations for the Diagnosis of Endometriosis
James A. Simon, MD, CCD, NCMP, IF, FACOG
Cut to the Chase: Why Not Treat Endometriosis With GnRH Antagonists First?
Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
Sawsan As-Sanie, MD
The Integral Role of GnRH Antagonists in the Management of Endometriosis
Changing the Paradigm in the Management of Endometriosis: Moving Away From “Surgery First” to “Pharmacologic Therapy First”
Parallels Between Kidney Transplantation and Maternal Anti-Fetal Rejection
Lee P. Shulman, MD, FACMG, FACOG
Alexandra Benachi, MD, PhD
Julien Zuber, MD, PhD
When to Begin FcRn: Initiation Criteria, Key Evidence
Can We Talk? Optimizing Patient Buy-In to the Management of Endometriosis
Strategies to Address Healthcare Disparities in Patients With Endometriosis
Pre- and Postoperative Use of GnRH Antagonists
Changing the Mindset in the Management of Endometriosis: Hitting the Pause Button on Surgical Procedures and Expanding the Role of GnRH Antagonists
Samantha Denäe
Why Are the Fetus and Placenta Not Rejected by the Mother? New Insights Into Maternal Anti-Fetal Rejection
Roberto Romero, MD, DMedSci
Targeting the Fc Receptor Pathway to Treat Red Blood Cell Alloimmunization
IBD & Intimacy: Managing an Under-Recognized Issue
Robert Frankel, MD
Neilanjan Nandi, MD
Loading...
We're glad to see you're enjoying Omnia Education… but how about a more personalized experience?
Press cancel to remain on Omnia Education. Press the link below or the continue button to keep going.